Citius Oncology Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.13

+0.02 (+1.80%)

As of Feb 8, 2:11 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +2,726.5% upside

Low Target $22.24

Average Target $31.94

High Target $42.20

Current Price $1.13

Current
$1.13

Target
$31.94

$22.24 $31.94 avg $42.20

Scenario Analysis

Bear Case

$22.24

1,868.1%

Low target

Base Case

$31.94

+2,726.5%

Avg target

Bull Case

$42.20

+3,634.5%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$39.69

-97.2% from high

52-Week Low

$26.22

+-95.7% from low

Target vs 52W High

$31.94

-19.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%